78 completed. 78 Phase 2, 12 Phase 1, 8 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 78 | Completed 78 |
| Phase 1 | 12 | Completed 12 |
| Phase 3 | 8 | Completed 8 |
Follow Disease: new trials by email Literature Review of Disease trials Research Report on Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase IIa Trial in Participants With Asthma to Evaluate Impact of Intranasal ETH47 on Development of Asthma-related Symptoms Following Rhinovirus Challenge ETH47, Placebo - Asthma (Diagnosis) | Phase 2 | Completed | Ethris GmbH | 50 | 2025-06-24 | 2026-11-03 |
| Contribution of PET/CT With Gallium 68 Citrate (68Ga-PET/CT) for the Diagnosis of Prosthetic Valve Infective Endocarditis 68Ga-citrate PET/CT - Infective Endocarditis | Phase 2 | Completed | University Hospital, Bordeaux | 19 | 2024-11-22 | 2026-08-27 |
| Comparison Between Effect of Empirical Antibiotic Prophylaxis Versus Enhanced Prophylactic Measures on Rate of Urinary Tract Infection After Flexible Ureteroscopy in Children With Pyuria Ceftriaxone (Rocephin®), Levofloxacin - Urinary Tract Infection (Diagnosis) | Phase 2 / Phase 3 | Completed | Ain Shams University | 140 | 2024-07-01 | 2025-11-17 |
| Therapeutic Vaccine in Patients With Human Papillomavirus HPV-positive Oropharyngeal Cancer HPVDC injection level dose 1, placebo injection level dose 1, HPVDC injection level dose 2 - Head and Neck Carcinoma, Adult Disease | Phase 1 / Phase 2 | Completed | Gustave Roussy, Cancer Campus, Grand Paris | 24 | 2023-07-31 | 2026-09-18 |
| Phase II Randomized Trial of Bethesda Protocol Compared to Cambridge Method for Detection of Early Stage Gastric Cancer in CDH1 Mutation Carriers Cellvizio (Registered trademark) Real-Time In Vivo Cellular Imaging Platform with Confocal Miniprobes, Olympus Graphics Interchange Format (GIF) 190 endoscope, Gastric mucosal biopsy - Gastric Cancer, Gastric Neoplasms | Phase 2 | Completed | National Cancer Institute (NCI) | 195 | 2023-06-22 | 2025-01-17 |
| OMT-28 in Patients With Primary Mitochondrial Disease (PMD) (PMD-OPTION) OMT-28 - Primary Mitochondrial Disease | Phase 2 | Completed | Omeicos Therapeutics GmbH | 28 | 2023-05-22 | 2026-01-22 |
| A Study to Investigate Safety and Tolerability of NDX-3315 and NDX-3324 in Healthy Participants and Patients With Eosinophilic Esophagitis NDX-3315, NDX-3324, SPECT/CT Imaging - Eosinophilic Esophagitis | Phase 2 | Completed | NexEos Diagnostics, Inc. | 34 | 2023-01-20 | 2026-05-14 |
| A Study of ANV419 Alone or in Combination With Approved Treatment in Patients With Cutaneous Melanoma (OMNIA-1). ANV419 - Melanoma (Skin), Cutaneous Melanoma | Phase 1 / Phase 2 | Completed | Anaveon AG | 29 | 2022-12-16 | 2025-08-26 |
| LYR-220 for Adult Subjects With Chronic Rhinosinusitis (BEACON Study) LYR-220 Design 1 (Part 1 only), LYR-220 Design 2 (Part 1 and Part 2), Bilateral sham procedure control (Part 2) - Chronic Sinusitis, Chronic Rhinosinusitis (Diagnosis) | Phase 2 | Completed | Lyra Therapeutics | 48 | 2021-11-23 | 2024-12-17 |
| Safety and Immunogenicity of RNA-based Vaccines Against SARS-CoV-2 Variants in Healthy Participants BNT162b2, Multivalent BNT162b2 (B.1.1.7 + B.1.617.2), Monovalent BNT162b2 (B.1.1.7) - SARS-CoV-2 Infection, COVID-19 | Phase 2 | Completed | BioNTech SE | 1380 | 2021-08-25 | 2024-11-22 |
| Clinical Trial Enzyme Application Targeting Venous Leg Ulcers Aurase Wound gel - Venous Leg Ulcer, Leg Injuries and Disorders | Phase 2 | Completed | SolasCure Limited | 43 | 2021-08-09 | 2023-02-15 |
| Subcutaneously CM310/Placebo in Patients With Chronic Rhinosinusitis With Nasal Polyposis (CROWNS-1) CM310, Placebo - Chronic Rhinosinusitis (Diagnosis), Nasal Polyps | Phase 2 | Completed | Keymed Biosciences Co.Ltd | 56 | 2021-04-06 | 2022-06-29 |
| Cyclosporine For The Treatment Of COVID-19(+) Cyclosporine, Standard of Care Treatment - SARS (Disease) | Phase 2 | Completed | Bryan Burt, MD | 47 | 2020-11-23 | 2023-07-20 |
| Study to Establish Image Interpretation Criteria for 18F Fluciclovine PET in Detecting Recurrent Brain Metastases (PURSUE) 18F fluciclovine - Brain Metastases | Phase 2 | Completed | Blue Earth Diagnostics | 23 | 2020-08-31 | 2025-07-20 |
| Experimental Study to Evaluate the Impact of 18 Fluoro-PSMA (18F-PSMA) PET / CT in the Management of Patients with Prostate Cancer. 18F-PSMA - 18F-PSMA, Prostate Cancer | Phase 2 | Completed | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | 550 | 2020-07-31 | 2025-01-09 |
| Functional Endoscopic Sinus Surgery Study Bupivacaine or Ropivacaine with epinephrine plus dexamethasone - Group 1, Bupivacaine or Ropivacaine with epinephrine plus dexamethasone - Group 2 - Chronic Rhinosinusitis (Diagnosis) | Phase 1 / Phase 2 | Completed | University of Florida | 80 | 2019-09-25 | 2026-07-30 |
| Ultrasound-Guided Injections for Meniscal Injuries in Active-Duty Military Lipogems, Normal Saline - Tibial Meniscus Injuries, Knee Injuries | Phase 2 | Completed | Kessler Foundation | 3 | 2019-07-01 | 2024-12-18 |
| Substance Misuse To Psychosis for Stimulants Aripiprazole, Paliperidone, Treatment as Usual - Stimulant Use With Stimulant-Induced Psychotic Disorder (Diagnosis), Schizophrenia and Related Disorders | Phase 2 / Phase 3 | Completed | The University of Hong Kong | 165 | 2019-06-01 | 2026-03-27 |
| LYR-210 Depot (LYR-210) for Adult Subjects With Chronic Sinusitis (LANTERN Study) LYR-210, Sham comparator - Chronic Sinusitis, Chronic Rhinosinusitis (Diagnosis) | Phase 2 | Completed | Lyra Therapeutics | 71 | 2019-05-09 | 2023-07-25 |
| Evaluation of the Precision and Sensitivity of Tilmanocept Uptake Value (TUV) on Tc 99m Tilmanocept Planar Imaging Tc 99m tilmanocept - Rheumatoid Arthritis | Phase 2 | Completed | Navidea Biopharmaceuticals | 116 | 2019-04-08 | 2023-08-24 |
Showing 20 of 78. Sign in to see all of them.
Breast Neoplasms (5) · Parkinsonian Disorders (5) · Syndrome (5) · Multiple Myeloma (4) · Neoplasms (4) · Alcoholism (3) · Neoplasm Metastasis (3) · Parkinson Disease (3) · Prostatic Neoplasms (3) · Alzheimer Disease (2) · Arthritis, Rheumatoid (2) · Binge-Eating Disorder (2) · Brain Neoplasms (2) · Bronchiolitis Obliterans Syndrome (2)
Pathological Conditions, Signs and Symptoms (78) · Pathologic Processes (77) · Neoplasms (23) · Neoplasms by Site (18) · Immune System Diseases (15) · Hemic and Lymphatic Diseases (13) · Neoplasms by Histologic Type (13) · Nervous System Diseases (12) · Skin and Connective Tissue Diseases (11) · Brain Diseases (10) · Central Nervous System Diseases (10) · Hematologic Diseases (10) · Nutritional and Metabolic Diseases (10) · Cardiovascular Diseases (9) · Mental Disorders (9)
Cyclophosphamide (3) · Cyclosporine (2) · Cytarabine (2) · Dexamethasone (2) · Exercise (2) · Fluticasone (2) · Formoterol Fumarate (2) · Gemcitabine (2) · Melphalan (2) · Paclitaxel (2) · Prazosin (2) · Prednisone (2) · Therapeutics (2) · carfilzomib (2) · pembrolizumab (2)
Institute for Neurodegenerative Disorders (5) · European Myeloma Network B.V. (3) · Dey (2) · Lyra Therapeutics (2) · National Cancer Institute (NCI) (2) · Sanofi (2) · Seattle Institute for Biomedical and Clinical Research (2) · University of California, San Francisco (2) · Ain Shams University (1) · Alcobra Ltd. (1) · Anaveon AG (1) · Ascenta Therapeutics (1) · Assistance Publique - Hôpitaux de Paris (1) · AstraZeneca (1) · BioNTech SE (1)
United States (47) · France (10) · Germany (8) · Italy (7) · Canada (6) · Spain (4) · United Kingdom (4) · Australia (3) · Austria (3) · Hungary (2) · New Zealand (2) · Poland (2) · Russia (2) · South Africa (2) · Sweden (2)
Christine Timko, PhD (2) · Kenneth L. Marek, MD (2) · Mario Boccadoro, MD (2) · Amy Kossert, MHK (1) · Andrew Blakely, M.D. (1) · Anita G Cramp, PhD (1) · Bryan Burt, MD (1) · Cameron R Smith (1) · Chi-yuan Hsu, MD (1) · Constance Dorian, BS Biology (1)
PMID 31221778, PMID 20593550, PMID 21388590, PMID 21396794, PMID 21515004, PMID 21631544, PMID 21982118, PMID 22634531, PMID 22763197, PMID 23011012, PMID 23098171, PMID 24687088, PMID 25540170, PMID 25628469, PMID 25703058, PMID 26719678, PMID 26888961, PMID 27036160, PMID 27404453, PMID 27992479, PMID 28388956, PMID 29489633, PMID 30149366, PMID 30153753, PMID 30220407, PMID 31183189, PMID 32107329, PMID 32800842, PMID 33012200, PMID 33595845, PMID 34012620, PMID 34081125, PMID 34110505, PMID 35797241, PMID 36378074, PMID 37188783, PMID 37208512, PMID 37483544, PMID 37527039, PMID 38167647, PMID 38398427, PMID 39097927, PMID 40320701, PMID 40525490, PMID 42656845
2014 (1), 2015 (1), 2018 (1), 2019 (1), K23DA015144 (1), P20AA017839 (1), P30CA015704 (1), R01AA015419 (1), R01AA017184 (1), R01NR012237 (1), R21AT003302 (1), R21DK114213 (1)